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The vesicular nucleotide transporter (VNUT) is involved
in the extracellular ATP effect on neuronal differentiation
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Abstract Before being released, nucleotides are stored
in secretory vesicles through the vesicular nucleotide
transporter (VNUT). Once released, extracellular ATP
participates in neuronal differentiation processes. Thus,
the expression of a functional VNUT could be an addi-
tional component of the purinergic system which regu-
lates neuronal differentiation and axonal elongation.
In vitro expression of VNUT decreases neuritogenesis
in N2a cells differentiated by retinoic acid treatment,
whereas silencing of VNUT expression increases the
number and length of neurites in these cells. These re-
sults highlight the role of VNUT in the neuritogenic
process because this transporter regulates the ATP con-
tent in neurosecretory vesicles.
Keywords VNUT . Neuritogenesis . Retinoic acid
differentiation . ATP . Neuroblastoma cells . SLC17A9
Abbreviations
VNUT Vesicular nucleotide transporter
RFP Red fluorescent protein
GFP Green fluorescent protein
N2a Neuro-2a
shRNA Small hairpin RNA
Introduction
Neurotransmission and neuroendocrine signaling depends on
the regulated release of a large variety of vesicular-stored sig-
naling molecules. Non-peptidergic compounds require specif-
ic vesicular transporters, all of them are members of the solute
carrier family (SLC) [1, 2]. Nowadays, it is widely accepted
that a single secretory vesicle contains more than one neuro-
transmitter and requires the presence of the corresponding
specific transporters in the membrane vesicles. ATP and a
large variety of nucleotidic compounds are among the most
frequent substances co-stored with the classical neurotrans-
mitters earlier discovered, such as acetylcoline, catechol-
amines, serotonine, and even glutamate, or other aminoacidic
compounds [3, 4]. To explain the complexity of signaling
events upon vesicular release, G. Burnstock coined the term
of co-transmission [5].
The abundant presence and distribution of secretory vesi-
cles containing ATP and other nucleotides require the under-
standing of their transport and storage [6]. Regarding this,
some previous work from our group contributed to the kinetic
characterization of the vesicular nucleotide transporter
(VNUT), showing its dependence on the pH gradient between
vesicles lumen and cytosol, its prominent mnemonic behavior
and the broad substrate specificity [7] . Recently, Moriyama’s
group cloned and identified VNUT as the product of the
SLC17A9 gene [8]. Proteoliposomes reconstituted with the
purified recombinant protein exhibit Δψ-driven and Cl− de-
pendent ATP transport. Expression in secretory tissues such as
adrenal gland and suppression by small interfering RNA,
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together with the concomitant reduction on ATP release, con-
firmed the SLC17A9 as the VNUT transporter.
Once released, ATP and the other stored nucleotides act on
their specific P2X ionotropic or P2Y metabotropic receptor
families, located in the same or neighboring cells [9, 10]. A
large number of ectonucleotidases accomplish the enzymatic
degradation of nucleotides to adenosine and inorganic phos-
phate, finishing their action on P2 receptors [11–13]. All the
molecules with a role in these cellular processes are grouped
under the name of purinome, and they are specific for different
cell types and physiopathological situations, which require a
convenient experimental model. Among these models, em-
bryonic hippocampal neurons and neuroblastoma N2a cell
line, where P2X7 receptors are functional and mainly located
at the axonal growth cone, have been proved to be suitable to
understand the sequence of purinergic events for axonal
growth and branching [14–16]. The presence of extracellular
ATP and its effect on P2X7 receptors reduces axonal growth
through a signaling cascade requiring intracellular Ca2+ in-
crease [17, 14]. In contrast, either degradation of ATP by
ectonucleotidases activity or antagonizing or silencing of
P2X7 receptors is able to increase axonal length [17]. How-
ever, the involvement of VNUT in the regulation of neural
differentiation and axonal elongation remains unknown. In
this report, we have analyzed the consequence of VNUT
expression/silencing in the process of neuritogenesis that oc-
curs in N2a cells after treatment with retinoic acid. Thus,
VNUT expression decreases the number and length of
neurites, and this effect is reversed by the silencing of VNUT
expression. These results indicate that the extracellular pres-
ence of ATP is linked to its vesicular content and availability
to be released, which directly involves the vesicular transport-
er VNUT in the neuritogenesis and differentiation processes.
Materials and methods
Plasmid constructs and design of shRNAs
Mouse VNUT (NM_183161) was amplified from IMAGE
consortium bacterial clone (IMAGE clone 4986674) by PCR
and ligated into the pcDNA3.1 (+)/myc-His A vector (Life
Technologies) generating VNUT flagged with c-myc epitope
(VNUT-myc). pRFP-C-RS vector obtained from Origene was
used as transfection control. VNUT knockdown was achieved
by RNA interference using a vector-based small hairpin
RNAs (shRNA) approach (pSUPER.neo.GFP, Oligoengine).
Several shRNA targets for VNUTwere designed according to
a previously reported rational-design protocol [18] and se-
quence 5′-GAACAAGAAGGAGGCTGGTATCGTGCTC
A-3′ was selected. Specificity of the sequence was confirmed
by a BLASTanalysis for mouse VNUT. As a control, we used
the firefly-luciferase-targeted oligonucleotide 5′-CTGACG
CGGAATACTTCGA-3′. Synthetic forward and reverse 64-
nucleotide oligonucleotides (Sigma-Aldrich) were designed,
annealed, and inserted into BglII-HindIII sites of the
pSUPER.neo.GFP vector following the manufacturer’s in-
structions. These plasmid constructs express shRNA targeted
against VNUT (shVNUT) or luciferase (non-targeting, shNT)
transcripts. The concomitant expression of GFP from this vec-
tor allowed transfected cells to be identified by fluorescence.
Cell culture
N2a cells were cultured in Dulbecco’s modified eagle medium
(DMEM, Sigma-Aldrich) supplemented with Glutamax®
(Invitrogen), penicillin/streptomycin (Invitrogen), and 10 %
heat-inactivated FBS (Gibco®, Life Technologies). Cells were
grown at 37 °C in a humidified atmosphere containing 5 %
CO2. For differentiation studies, cells were seeded at a density
of 105 cells/cm2 in low-serum medium (DMEM containing
0.5 % FBS) supplemented with 10 μM retinoic acid (Sigma-
Aldrich), renewed every 2 days as described by Tremblay
et al. (2010) [19]. The assays were performed on day five of
differentiation.
Transfections
N2a cells were plated at 8×105 cell/cm2 in 6-well plates and
transiently transfected with 2.5 μg of the different plasmids
using Lipofectamine™ 2000 (Life Technologies) following
the manufacturer’s instructions. After 6 h, the medium was
removed and the cells were further incubated for the indicated
time periods in DMEM supplemented with Glutamax®
(Invitrogen), penicillin/streptomycin (Invitrogen), and 10 %
heat-inactivated FBS. In the case of co-transfections with
two plasmids, 1.25 μg was used for each plasmid in order
not to exceed total DNA quantity.
RT-PCR and quantitative real-time PCR
Total RNA was purified from cultured N2a cells using a
SpeedTools Total RNA Extraction kit (Biotools) according
to the manufacturer’s instructions. After digestion with TUR-
BO DNase (Ambion), 1 μg of total RNAwas quantified and
reversed transcribed using M-MLV reverse transcriptase, 6 μg
of random primers, and 350 μM dNTPs (all from Invitrogen).
The quantitative real-time PCR (qPCR) reaction were carried
out using LuminoCt qPCR ReadyMix (Sigma-Aldrich), 5 μl
of the cDNA previously synthesized and 1.25 μl of specific
commercial oligonucleotide primers for mouse VNUT
(TaqMan® Gene Expression Assay, Life Technologies Assay
ID Mm00805914_m1), as well as for the housekeeping gene
glyceraldehyde 3-phosphate dehydrogenase (GAPDH,
TaqMan® Gene Expression Assay, Life TechnologiesAssay
ID Mm99999915_g1) in 25 μl final volume. The reaction
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was realized in a StepOnePlus Real-Time PCR System (Ap-
plied Biosystems) as follows: denaturation, one cycle of 95 °C
for 20 s, followed by 40 cycles each of 95 °C for 1 s and 60 °C
for 20 s. The results were normalized as indicated by parallel
amplification of the endogenous housekeeping gene GAPDH.
Western blotting
N2a cells were lysed and homogenized for 1 h at 4 °C in lysis
buffer containing 50 mM Tris/HCl, 150 mM NaCl, 1 %
Nonidet P40 and CompleteTM Protease Inhibitor Cocktail
Tablets (Roche Diagnostics GmbH), pH 7.4. Separation of
the proteins was performed on 10% SDS-PAGE gels. Proteins
were transferred to nitrocellulose membranes, blocked for 1 h
at room temperature (RT) with 5 % nonfat dried milk in
tween-phosphate-buffered saline (137 mM NaCl, 2.7 mM
KCl, 5 mM Na2HPO4-7H20, 1.4 mM KH2PO4, and 0.1 %
Tween; pH 7.4) (PBS-T), and incubated overnight at 4 °Cwith
anti-c-myc antibody (Invitrogen) at 1:2500 or anti-α-tubulin
antibody (Sigma-Aldrich) at 1:10,000. Blots were then
Fig. 1 Characterization of
molecular tools to study
expression or silencing of VNUT
expression in N2a cells. a
Schematic representation of the
construct used for expression of
VNUT in N2a cells. b VNUT
mRNA levels analyzed by qPCR
of transfected N2 cells with
VNUT-myc and either shNT or
shVNUT. shNTwas used as
negative control. The values
represent the mean±SEM (n=3,
***P<0.001, unpaired Student’s t
test). cWestern blotting of
untransfected N2a cells or N2a
cells transfected with either
VNUT-myc and shNT or
shVNUT. α-Tubulin was used as
internal loading control. Graph
bars represent the mean±SEM
(n=3, **P<0.01, unpaired
Student’s t test). d Representative
confocal images showing
immunostaining against c-myc
epitope fused to VNUT (red) and
synaptophysin (green) of N2a
cells transfected with VNUT-
myc. Nuclei are counterstained
with DAPI (blue). Scale bar
10 μm. Inset represents 4×
magnification of indicated cell.
Arrows indicate the most
prominent VNUT and
synaptophysin positive vesicles.
5 μm
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washed in PBS-T, and incubated for 1 h at RTwith goat anti-
mouse IgGs coupled to horseradish peroxidase (Dako), at
1:5000 dilution. Protein bands were detected by ECL chemi-
luminescence (Amersham GE Healthcare). The expression of
VNUTwas standardized by the expression of α-tubulin of the
same experiment. Images were captured with ImageQuant
LAS 500 (GE Healthcare Life Sciences) and analyzed using
ImageQuant TL.
ATP release measurement
ATP re l ea se was measu red us ing ENLITEN®
rLuciferase/Luciferin reagent (Promega). Culture medium
(100 μl) was collected under various experimental con-
ditions and centrifuged at 600×g for 5 min at 4 °C, and
10 μl aliquots of supernatant were transferred to wells of
a 96-well plate placed on ice. Before the start of the
experiments, N2a cells were bathed in Mg2+-free Locke’s
buffer supplemented with 100 μM ARL 67156, a
competitive inhibitor of ecto-ATPases [20] for 30 min
at 37 °C and the medium was collected to measure basal
Fig. 2 Expression of a functional VNUT in N2a cells after differentiation
with retinoic acid. a Western blotting of untransfected or transfected
differentiated N2a cells with VNUT-myc after a 5-day differentiation
process with retinoic acid (10 μM). b qPCR of VNUT mRNA levels of
differentiated N2a cells transfected with different plasmids. N2a cells
were transfected with control plasmid, VNUT-myc+shNT or VNUT-
myc+shVNUT as indicated. The values represent the mean±SEM (n=
3, **P<0.01, ***P<0.001, ANOVA with the Tukey’s multiple
comparisons test) normalized by the content of GAPDH transcript. c
Luminescence activity of ATP release to the extracellular medium by
transfected N2a cells without any stimulation. Luminescence was
normalized against control cells. The values represent the mean±SEM
(n=3, non-significant, ANOVA with the Tukey’s multiple comparisons
test). d Luminescence activity of ATP release to the extracellular medium
by transfected N2a cells after stimulation with Ca2+ ionophore ionomycin
(2 μM). Luminescence was normalized against control cells. The values
represent the mean±SEM (n=3, **P<0.01, ANOVA with the Tukey’s
multiple comparisons test)
Fig. 3 Expression of VNUT decreases neuritogenesis in differentiated
N2a cells. a Representative confocal images of transfected N2a cells with
control (RFP) (upper panels) or VNUT-myc (lower panels). Transfected
control cells were identified by RFP fluorescence and cells expressing
VNUT by anti-c-myc antibody (red). N2a cells were immunostained with
anti-β-III tubulin antibody (green) for the morphological analysis. Nuclei
were counterstained with DAPI. Scale bar: 25 μm. b Percentage of
transfected N2a cells without neurites or with neurite length lower than
soma diameter (<SD, 10 μm), or higher than once SD (>1SD, 10 μm) or
twice SD (>2SD, 20 μm). N2a transfected with control RFP are
represented by black bars and N2a transfected with VNUT by gray
bars (n=6, *P<0.05, **P<0.01, ANOVA with Sidak’s multiple
comparisons test). c Boxplot representation of the main neurite length
in micrometer. Wiskers contains 10–90 % of total measures
(***P>0.001 with Kolmogorov-Smirnov analysis on the cumulative
frequency). d Percentage of transfected N2a cells with different number
of neurites. N2a transfected with RFP are represented by black bars and
N2a transfected with VNUT by gray bars. Data show the mean±SEM of
70 cells (n=6, *P<0.05, **P<0.01, ANOVA with Sidak’s multiple
comparisons test)
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ATP. Then, cells were stimulated by adding ionomycin
(2 μM final concentration). Five minutes later, extracel-
lular medium was again collected to measure evoked
ATP concentration. The 96-well plate was set in a
FLUOstar OPTIMA Microplate Luminometer (BMG
LABTECH GmbH), and 100 μl of rLuciferase/Luciferin
reagent was automatically injected into each well at RT
(25 °C).
Immunocytochemistry
N2a-transfected cells cultured on coverslips placed in 35-
mm dishes were fixed with 4 % PFA for 15 min and
rinsed with PBS twice for 10 min. Afterwards, cells on
coverslips were permeabilized in blocking solution (Tri-
ton X-100 0.1 %, FBS 5 %, and BSA 10 % in PBS) for
1 h at RT. This was followed by incubation with primary
antibodies: anti-c-myc (1:200), anti-β-III tubulin
(1:1000) (Promega) and anti-synaptophysin (1:200) (Syn-
aptic Systems). Subsequently, cells were washed with
PBS three times and incubated for 1 h at RT with Alexa
Fluor 594® donkey anti-rabbit, Alexa Fluor 488® goat
anti-mouse, and Alexa Fluor 647® goat anti-mouse (all
from Invitrogen). Nuclei were counterstained with 4′,6-
diamidino-2-phenylindole (DAPI, Invitrogen), a fluores-
cent stain that binds strongly to DNA. Coverslips were
mounted on glass slides using FluoroSaveTM Reagent
(Calbiochem). Images were acquired using a confocal
laser microscope (Leica TCS SPE) using 20× W/IR ob-
jective lenses. The analysis of neurite length and ramifi-
cations was carried out using Image J v1.49j (NIH) and
Neuron J plugin v1.4.2 [21]. Neurite outgrowth was
quantified by determining the percentage of cells that
present neurites once or twice longer than the soma di-
ameter (SD) as described by Ravichandra and Joshi
(1999) [22]. Ten different fields in the culture dishes
containing 70 cells in each field were randomly selected
and counted. The mean percentage of neurite-bearing
cells was obtained for each culture. Each assay was re-
peated six times in three independent cultures.
Statistical analysis
Data are shown as mean values±standard error of the
mean (SEM). All experiments shown were reproduced
3–6 independent times. Figures and statistical analyses
were generated using GraphPad Prism 6 (GraphPad Soft-
ware). Results were analyzed by unpaired Student’s t test
or ANOVA with Tukey or Sidak’s multiple comparisons
test as indicated. Neurite length was compared using
Kolmogorov-Smirnov analysis on the cumulative fre-
quency distribution. The statistical test used and P values
are both indicated in each figure legend. P≤0.05 was
considered statistically significant.
Results
Design of molecular tools for VNUT expression
In order to validate the molecular tools used in this study, N2a
cells were transfected with the designed constructs VNUT-
myc (Fig. 1a) and shRNAs either control (shNT) or specifi-
cally designed against VNUT (shVNUT). After 24 h, the
transfection efficiency was about 85 % and mRNA and pro-
tein levels of VNUT were analyzed by qPCR (Fig. 1b) and
Western blotting (Fig. 1c), respectively. These experiments
demonstrated that VNUT is successfully expressed in
transfected N2a cells. Moreover, the expression of this trans-
porter was reduced when N2a cells were co-transfected with
VNUT-myc and shVNUT (Fig. 1b, c). Likewise, immunocy-
tochemistry assays were performed incubating transfected
N2a cells with anti-c-myc antibody, and a vesicular co-
localization with vesicular marker synaptophysin could be
observed in confocal fluorescence images (Fig. 1d).
Retinoic acid-induced N2a differentiation keeps VNUT
overexpression in transfected cells
Transfected N2a cells were submitted to retinoic acid
differentiation according to Tremblay et al. (2010) [19].
Western blotting and qPCR assays were performed to
confirm that expression of VNUT is maintained in dif-
ferentiated N2a cells. After 5 days with retinoic acid,
VNUT mRNA and protein levels were analyzed. The
expression of the transporter was detected in differentiat-
ed N2a cells co-transfected with VNUT and shNT by
Western blotting (Fig. 2a) and qPCR (Fig. 2b) assays.
Fig. 4 Knockdown of VNUT expression increases neuritogenesis in
differentiated N2a cells. a Representative confocal images of N2a cells
co-transfected with VNUT-myc and either shNT (upper panels) or
shVNUT (lower panels). Transfected cells were identified by GFP
fluorescence (blue). N2a cells were immunostained with anti-c-myc
(red) and anti-β-III tubulin (green) antibodies. Scale bar: 25 μm. b
Percentage of transfected N2a cells without or with neurite length lower
than soma diameter (<SD, 10μm) or higher than once SD (>1SD, 10μm)
or twice SD (>2SD. 20 μm). N2a transfected with VNUT+ shNT are
represented by black bars and N2a transfected with VNUT+ shVNUT
by gray bars (n=6, *P<0.05, **P<0.01, ANOVAwith Sidak’s multiple
comparisons test). c Boxplot representation of the main neurite length in
micrometer. Wiskers contains 10–90% of total measures (**P>0.01with
Kolmogorov-Smirnov analysis on the cumulative frequency). d
Percentage of transfected N2a cells with different number of neurites.
N2a transfected with VNUT+ shNT are represented by black bars and
N2a transfected with VNUT+ shVNUT by gray bars. Data show the
mean±SEM of 70 cells (n=6, *P<0.05, **P<0.01, ANOVA with
Sidak’s multiple comparisons test)
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The reduction on the expression of VNUT after 5 days of
differentiation, compared with cells freshly transfected,
was caused by the loss of transfected cells associated to
transient transfections, where only about 15 % of cells
remain transfected. On the other hand, VNUT mRNA
levels were reduced in differentiated N2a cells co-
transfected with VNUT and shVNUT (Fig. 2a, b). Fur-
thermore, the functionality of the vesicular transporter
was confirmed by using the luciferin-luciferase assay to
quantify the luminescence signal produced by the re-
leased ATP (Fig. 2c). Previous studies demonstrated that
N2a cells have a mechanism of ATP release depending
on the increase in intracellular [Ca2+], involving the exo-
cytotic machinery [16]. Differentiated N2a cells were
stimulated with Ca2+-selective ionophore, ionomycin
2 μM, for 5 min and extracellular medium was collected
with or without stimulation. Cells co-transfected with
VNUT and shNT showed the highest values of lumines-
cence, which decreased when co-transfected with VNUT
and shVNUT (Fig. 2c, d). These results indicate that the
vesicular nucleotide transporter is functional when it was
expressed in differentiated N2a cells and kept functional
during retinoic acid differentiation process.
Neuritogenesis is reduced in N2a overexpressing VNUT
After verification that VNUT is functional and its expres-
sion remains in differentiated N2a cells, we wanted to
analyze the possible effects that expression of VNUT
could produce in the neuritogenesis of these cells. To
study the probable morphological changes, N2a cells
were transfected either with control or VNUT-myc con-
struct, and identified by immunostaining with anti-c-myc
antibody (for VNUT-myc-transfected cells) or RFP fluo-
rescence from pRFP-C-RS vector as transfection control
(Fig. 3a). This vector has a red fluorescent protein
(RFP)-coding sequence which allows to identify
transfected cells (Fig. 3a). A specific anti-β-III tubulin
antibody was used to observe the neuronal morphology
(Fig. 3a) and go ahead with the quantification of
neurites.
In N2a cells that expressed VNUT the percentage of
cells without neurites was significantly increased com-
pared to control (30.0 %±5.0 versus 11.8 %±2.9)
(Fig. 3b and d). Similarly, the expression of VNUT de-
creased the median of length of the principal neurite
13.07 μm for VNUT transfected cells compared with
20.00 μm for control cells (Fig. 3c) (P<0.0001 with
Kolmogorov-Smirnov analysis on the cumulative fre-
quency distribution). In addition, if a distribution of cells
is made accordingly to neurite length, the expression of
VNUT increases the percentage of cells with neurites
shorter than the soma diameter (SD 10 μm) (49.9±
5.7 % versus 31.9±6.9 %) (Fig. 3b). Otherwise, the per-
centage of cells with neurites longer than SD (>10 μm)
(50.4±4.5 % versus 68.1±6.9 %) and neurites twice lon-
ger than SD (>20 μm) (28.3±2.2 % versus 46.8±5.5 %)
decreased in those cells that expressed VNUT (Fig. 3b).
In the same way, expression of VNUT decreased the
percentage of cells with two (26.2±4.5 % versus 36.6±
5.8 %), three (9.2±3.3 % versus 14.9±3.9 %), and four
or more (2.5±1.1 % versus 7.3±3.1 %) neurites com-
pared to control cells (Fig. 3c).
VNUT knockdown restores differentiation process in N2a
cell line
In order to corroborate that the observed effect in the differ-
entiation of N2a cells is due to expression of the vesicular
transporter, shVNUT was used to knockdown its expression.
N2a cells were co-transfected with VNUT-myc and either
shNT (control) or shVNUT. Cells co-transfected with both
plasmids were identified by shRNA-GFP fluorescence emis-
sion and anti-myc immunolabeling addressed to detect
VNUT-myc (Fig. 4a). The knockdown of VNUT increased
the median of length of the principal neurite, from 9.1 μm
for VNUTand shNTcells to 18.3 μm for VNUTand shVNUT
transfected cells (Fig. 4c) (P<0.001 with Kolmogorov-
Smirnov analysis on the cumulative frequency distribution).
The knockdown of VNUT expression decreased the percent-
age of cells without neurites (33.4±11.7 % to 14.5±1.5 %)
(Fig. 4b). Likewise, the same effect was observed in cells with
neurites shorter than SD (<10 μm) whose percentage signifi-
cantly decreased (64.7±3.9 % to 37.7±2.3 %) (Fig. 4c). How-
ever, the percentages of cells with both neurites longer than
SD (>10 μm) (35.2±3.8 % to 62.3±2.3 %) (Fig. 4c) and
neurites twice as long as SD (>20 μm) (15.3±2.3 % to 32.1
±0.1 %) were increased compared to N2a cells co-transfected
with VNUT and shNT. Regarding the number of neurites, the
effect of VNUT knockdown was not as evident as in the ob-
served neurite outgrowth (Fig. 4d). These results indicate that
the reduction of VNUTexpression increases neuritogenesis in
differentiated N2a cells.
Fig. 5 VNUT is a component of the purinergic machinery required for
control of axonal growth and neuritogenesis. ATP is stored in secretory
vesicles through VNUT; this transporter uses the generated gradient (Δ
μH+) by V-ATPase to translocate ATP into vesicles. ATP is released to
extracellular medium through calcium-dependent mechanism. Once
released, ATP can activate purinergic receptors, such as P2X7, in an
autocrine manner that results in various physiological cellular events.
Simultaneously, ATP can be degraded to its metabolites by
ectonucleotidases activity. a The abundant presence of extracellular
ATP induces P2X7 activation, and the intracellular Ca2+ increases
results on axonal length and neuritogenesis reduction in this cellular
model [16]. b On the contrary, a decrease or destruction of extracellular
ATP results in an increase of axonal length and branching
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Discussion
The aim of this experimental work was to demonstrate that the
vesicular nucleotide transporter (VNUT) is a key component
required to accomplish the cellular biological events involving
extracellular ATP in neurosecretory cells. Nucleotide P2X and
P2Y receptors are present in most mammalian cells, and
their physiological or pathological signaling are unveiled
step by step [9, 23, 24]. For secretory cells, the cloning
and characterization of the elusive VNUT opened new
possibilities of understanding the ATP extracellular cycle
and its relation with secretory tissues-related diseases [8,
25–27]. The first tissues studied were from neural or neu-
roendocrine origin, and the presence of VNUT was dem-
onstrated by immunohistochemistry and RNA in situ hy-
bridization [28–30]. It is worth emphasizing that synaptic
vesicles and chromaffin cell granules are able to store
ATP and other nucleotides up to 0.1 M, among them are
the diadenosine polyphosphates which are agonists on
several P2X and P2Y receptors [31].
Neuroblastoma N2a cell line has proved to be a valuable
model to analyze cell biology events and consequently select-
ed to understand the role of VNUT in neural differentiation
events [14, 15]. A simplified scheme of this process is shown
in Fig. 5. On the other hand, these cells express very small
amounts of endogenous VNUT, which was a requisite for
better understanding of the expression effects [16]. Expression
of the VNUT in secretory cells has already been reported in
PC12 cells, a chromaffin cell model, being able to increase
ATP secretion in depolarizing conditions [8]. In our model,
expression of VNUT co-localizes with the vesicular marker
synaptophysin, and as reported for PC12 cell line, the mem-
brane depolarization increases the ATP release. These results
are important experimental facts to consider VNUTas a func-
tional transporter. Furthermore, sustained expression of
VNUT is observed when N2a cells are subjected to retinoic
acid differentiation, this being a necessary condition to evalu-
ate the ATP effects on neuritogenesis and differentiation.
In this regard, expression of VNUT clearly reduces the
neuritogenic processes in N2a cells compared to control cells.
Changes induced in the cellular morphology allow a precise
quantification and comparison of length of neurite processes
in VNUTexpressing and non-expressing cells. Additional ex-
periments to corroborate the VNUT negative effect on
neuritogenic processes required N2a cells co-transfected with
VNUT and a knockdown, shVNUT. These cells, where
VNUT expression was reduced, recovered their morphology
with more prominent neuritogenic processes. This confirms
the hypothesis of VNUT is involved in neuronal differentia-
tion as part of a mechanism requiring extracellular ATP acting
through P2X7 receptor at the axonal growth cone [32, 14, 17].
The physiological relevance and future perspectives of VNUT
as a pharmacological target derive from its capacity to increase
extracellular ATP levels. ATP vesicular release has also been
reported from the mucin granules of airway epithelial cells,
microglia, and a large variety of neuroendocrine secretory
tissues [33, 25, 30]. The physiopathological role of extracel-
lular ATP and its exocytotic release in many tissues supports
VNUT as a new and relevant pharmacological target.
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